News

Say goodbye to cheap versions of Ozempic and Wegovy
This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...
FDA stops sale of copycat versions of Ozempic and Wegovy: What to do if you’re taking them
Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...
Novo Nordisk's Stellar Wegovy-Fuelled Run of Hiking Sales Guidance Could Be Ending
But recent weak U.S. prescription data is leading some investors and analysts to question whether that stellar run, which ...
The Washington Post5d
Americans spent $71 billion on GLP-1 drugs in 2023
GLP-1 drugs include Ozempic and Rybelsus, both of which have been approved by the Food and Drug Administration to treat diabetes. They also include Saxenda and Wegovy, which the FDA approved for ...